Dr Arnfin Bergmann MD, CEO of NeuroTransData GmbH, highlighted the AI-PROGNOSIS project during networking and informal discussions at the AAN 2025 Annual Meeting, hosted by the American Academy of Neurology.

Although not part of the official programme, the event provided a valuable opportunity to connect with international professionals and share the goals and progress of AI-PROGNOSIS in the field of Parkinson's disease.

The Annual Meeting brought together over 14,500 neurology professionals from 110 countries and all 50 US states, along with more than 300 exhibitors. It was a dynamic week of scientific exchange, innovation, and global collaboration focused on advancing neurological care.

Participation in such high-level events supports the visibility and outreach of the AI-PROGNOSIS initiative – bringing AI-driven innovation closer to clinical application in early diagnosis and personalised care.